Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription

Articles published in Exp Gerontol

Retrieve available abstracts of 39 articles:
HTML format

Single Articles

    November 2022
  1. EZZATI A, Pak VM
    The effects of time-restricted eating on sleep, cognitive decline, and Alzheimer's disease.
    Exp Gerontol. 2022 Nov 17:112033. doi: 10.1016/j.exger.2022.112033.
    PubMed     Abstract available

    October 2022
  2. SAYEHMIRI F, Khodagholi F, Pourbadie HG, Naderi N, et al
    Phosphonate analog of 2-oxoglutarate regulates glutamate-glutamine homeostasis and counteracts amyloid beta induced learning and memory deficits in rats.
    Exp Gerontol. 2022;168:111944.
    PubMed     Abstract available

    September 2022
  3. ABUELEZZ NZ, Nasr FE, Abdel Aal WM, Molokhia T, et al
    Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population.
    Exp Gerontol. 2022;169:111961.
    PubMed     Abstract available

  4. HE X, Yan C, Zhao S, Zhao Y, et al
    The preventive effects of probiotic Akkermansia muciniphila on D-galactose/AlCl3 mediated Alzheimer's disease-like rats.
    Exp Gerontol. 2022 Sep 21:111959. doi: 10.1016/j.exger.2022.111959.
    PubMed     Abstract available

  5. COUTINHO LA, Leao LL, Cassilhas RC, de Paula AMB, et al
    Alzheimer's disease genes and proteins associated with resistance and aerobic training: An in silico analysis.
    Exp Gerontol. 2022 Sep 7:111948. doi: 10.1016/j.exger.2022.111948.
    PubMed     Abstract available

  6. NABIZADEH F, Kankam SB, Balabandian M, Hashemi SM, et al
    Metformin use and brain atrophy in nondemented elderly individuals with diabetes.
    Exp Gerontol. 2022;166:111890.
    PubMed     Abstract available

  7. KAMENO K, Hasegawa Y, Hayashi K, Takemoto Y, et al
    Loss of body weight in old 5xFAD mice and the alteration of gut microbiota composition.
    Exp Gerontol. 2022;166:111885.
    PubMed     Abstract available

    August 2022
  8. PLACIDO J, de Almeida CAB, Ferreira JV, de Oliveira Silva F, et al
    Spatial navigation in older adults with mild cognitive impairment and dementia: A systematic review and meta-analysis.
    Exp Gerontol. 2022;165:111852.
    PubMed     Abstract available

  9. GARCIA-VELAZQUEZ L, Lopez-Carrasco P, Arias C
    Age-dependent changes in Wnt signaling components and synapse number are differentially affected between brain regions.
    Exp Gerontol. 2022;165:111854.
    PubMed     Abstract available

  10. KURAPOVA R, Chouliaras L, O'Brien JT
    The promise of amplification assays for accurate early detection of alpha-synucleinopathies: A review.
    Exp Gerontol. 2022;165:111842.
    PubMed     Abstract available

    July 2022
  11. AKUSHEVICH I, Yashkin AP, Kravchenko J, Kertai MD, et al
    Extended anesthesia exposure for abdominal and pelvic procedures in older adults with colorectal cancer: Associations with chart dementia diagnoses.
    Exp Gerontol. 2022;164:111830.
    PubMed     Abstract available

    May 2022
  12. REISS AB, Ahmed S, Dayaramani C, Glass AD, et al
    The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
    Exp Gerontol. 2022 May 1:111828. doi: 10.1016/j.exger.2022.111828.
    PubMed     Abstract available

    April 2022
  13. BAZRGAR M, Khodabakhsh P, Dargahi L, Mohagheghi F, et al
    MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid betaeta oligomer induced Alzheimer's like rat model.
    Exp Gerontol. 2022;164:111812.
    PubMed     Abstract available

    January 2022
  14. GLASMAN P, Houot M, Migliaccio R, Bombois S, et al
    Subtle postoperative cognitive disorder in preclinical Alzheimer's disease.
    Exp Gerontol. 2022 Jan 29:111715. doi: 10.1016/j.exger.2022.111715.
    PubMed     Abstract available

  15. TARBALI S, Zahmatkesh M, Torkaman-Boutorabi A, Khodagholi F, et al
    Assessment of lipophilic fluorescence products in beta-amyloid-induced cognitive decline: A parallel track in hippocampus, CSF, plasma and erythrocytes.
    Exp Gerontol. 2022;157:111645.
    PubMed     Abstract available

    August 2021
  16. LI P, Wu Q, Li X, Hu B, et al
    Shenqi Yizhi Granule attenuates Abeta1-42 induced cognitive dysfunction via inhibiting JAK2/STAT3 activated astrocyte reactivity.
    Exp Gerontol. 2021;151:111400.
    PubMed     Abstract available

    July 2021
  17. VASCONCELOS-FILHO FSL, da Rocha Oliveira LC, de Freitas TBC, de Pontes PADS, et al
    Effect of involuntary chronic physical exercise on beta-amyloid protein in experimental models of Alzheimer's disease: Systematic review and meta-analysis.
    Exp Gerontol. 2021 Jul 30:111502. doi: 10.1016/j.exger.2021.111502.
    PubMed     Abstract available

  18. VATANABE IP, Pedroso RV, Manzine PR, Chagas MHN, et al
    ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty.
    Exp Gerontol. 2021;149:111303.
    PubMed     Abstract available

    June 2021
  19. GALLO A, Pillet LE, Verpillot R
    New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids.
    Exp Gerontol. 2021;152:111452.
    PubMed     Abstract available

    May 2021
  20. CEZAR NOC, Aprahamian I, Ansai JH, de Oliveira MPB, et al
    Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX).
    Exp Gerontol. 2021;150:111390.
    PubMed     Abstract available

  21. LIU L, Cao J, Huang C, Yuan E, et al
    Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse.
    Exp Gerontol. 2021;147:111274.
    PubMed     Abstract available

  22. YANG I, Arthur RA, Zhao L, Clark J, et al
    The oral microbiome and inflammation in mild cognitive impairment.
    Exp Gerontol. 2021;147:111273.
    PubMed     Abstract available

    April 2021
  23. TZEKAKI EE, Tsolaki M, Pantazaki AlphaA, Geromichalos G, et al
    The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system.
    Exp Gerontol. 2021 Apr 6:111344. doi: 10.1016/j.exger.2021.111344.
    PubMed     Abstract available

    March 2021
  24. XIAO QY, Ye TY, Wang XL, Han L, et al
    A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease.
    Exp Gerontol. 2021 Mar 27:111336. doi: 10.1016/j.exger.2021.111336.
    PubMed     Abstract available

  25. PINI L, Wennberg AM
    Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.
    Exp Gerontol. 2021;145:111216.
    PubMed     Abstract available

    February 2021
  26. EGASHIRA R, Umezaki Y, Mizutani S, Obata T, et al
    Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
    Exp Gerontol. 2021;144:111189.
    PubMed     Abstract available

    January 2021
  27. FERNANDEZ FX, Kaladchibachi S, Negelspach DC
    Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease.
    Exp Gerontol. 2021;147:111258.
    PubMed     Abstract available

  28. BLASKO I, Defrancesco M, Oberacher H, Loacker L, et al
    Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease.
    Exp Gerontol. 2021 Jan 28:111264. doi: 10.1016/j.exger.2021.111264.
    PubMed     Abstract available

  29. YAN T, Liu B, Wang N, Liao Z, et al
    The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in Abeta1-42 induced mouse model of Alzheimer's disease.
    Exp Gerontol. 2021;147:111263.
    PubMed     Abstract available

  30. SOYSAL P, Tan SG, Smith L
    A comparison of the prevalence of Fear of Falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia.
    Exp Gerontol. 2021;146:111248.
    PubMed     Abstract available

  31. AL-HARRASI AM, Iqbal E, Tsamakis K, Lasek J, et al
    Motor signs in Alzheimer's disease and vascular dementia: Detection through natural language processing, co-morbid features and relationship to adverse outcomes.
    Exp Gerontol. 2021 Jan 12:111223. doi: 10.1016/j.exger.2020.111223.
    PubMed     Abstract available

    December 2020
  32. TZEKAKI EE, Papaspyropoulos A, Tsolaki M, Lazarou E, et al
    Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.
    Exp Gerontol. 2020 Dec 5:111178. doi: 10.1016/j.exger.2020.111178.
    PubMed     Abstract available

  33. LIU Q, Lei C
    Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Exp Gerontol. 2020;144:111187.
    PubMed     Abstract available

  34. ZHANG J, Wang R
    Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-beta induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Exp Gerontol. 2020;144:111180.
    PubMed     Abstract available

  35. SCHIMIDT HL, Carrazoni GS, Garcia A, Izquierdo I, et al
    Strength training or green tea prevent memory deficits in a beta-amyloid peptide-mediated Alzheimer's disease model.
    Exp Gerontol. 2020;143:111186.
    PubMed     Abstract available

    September 2020
  36. YADAV J, Verma AK, Garg RK, Ahmad K, et al
    Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer's disease.
    Exp Gerontol. 2020 Sep 26:111092. doi: 10.1016/j.exger.2020.111092.
    PubMed     Abstract available

    April 2020
  37. ELSWORTHY RJ, Aldred S
    The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation.
    Exp Gerontol. 2020;132:110838.
    PubMed     Abstract available

    February 2020
  38. YAN T, Nian T, Wu B, Xiao F, et al
    Okra polysaccharides can reverse the metabolic disorder induced by high-fat diet and cognitive function injury in Abeta1-42 mice.
    Exp Gerontol. 2020;130:110802.
    PubMed     Abstract available

  39. LIN X, Chen Y, Zhang P, Chen G, et al
    The potential mechanism of postoperative cognitive dysfunction in older people.
    Exp Gerontol. 2020;130:110791.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.